ESG innovation among pharma companies has dropped off in the last year
An analysis of patent applications indicates that pharma innovation in the environmental, social, and governance space has reduced
By
Social
Latest in
Social
North America is seeing a hiring boom in pharmaceutical industry ESG roles
The US saw 47.6% of all ESG job adverts in the three months ending November this year, up from 43.1%…
By
Macro view: Omicron outbreak forces lockdown in New South Wales
Some economists state that the Omicron outbreak has sparked a de facto lockdown in New South Wales, forcing businesses to…
ESG in clinicals trials: What pharma needs to know
AI is main investment target, while 3D printing remains a largely untapped area.
By
Asia-Pacific is seeing a hiring boom in pharmaceutical industry ESG roles
The number of roles in Asia-Pacific made up 9.4% of total ESG jobs.
By
Inside Cervest’s plan to map the world’s climate risk
Envirotech startup Cervest is building an AI platform that can map the world's climate risk and provide businessses with climate…
Why the Online Safety Bill fails, and what can make the internet safer
Why the Online Safety Bill fails, what it gets right and how the internet can be made a safer space…
Was Covid-19 the jab needed to make companies fight fake news?
F-Secure, Adobe and O'Reilly speak to Giacomo Lee on how fake news regulation will need more than AI and intelligence…